Home nocturnal supplemental nasogastric feedings in growth-retarded adolescents with Crohn's disease

Gastroenterology
H AigesF Daum

Abstract

We hypothesized that supplemental nutritional support delivered at home by nocturnal nasogastric feedings would result in accelerated growth in growth-retarded adolescents with Crohn's disease. Eight Tanner stage I adolescents with Crohn's disease, mean age 14 yr 5 mo, had a mean weight gain of 0.38 kg and height gain of 1.4 cm for the year before initiation of nasogastric feedings. All had been either asymptomatic or had only minimal symptoms in the year before the study, but were ingesting only 55%-80% of their daily required caloric intake. The subjects were taught to pass by themselves a nasogastric feeding tube, through which 1000-1500 ml of commercial, nonelemental isocaloric formula was infused during sleep to supplement their usual dietary intake. After 12 mo of nocturnal feedings, the subjects had a mean weight gain of 11.75 kg and a mean height gain of 6.98 cm. Six control subjects, matched for age and degree of growth and sexual retardation at the beginning of the study period, but who had refused the nasogastric feedings, had no change in weight and height during the same period of observation. We conclude that home nocturnal nasogastric feedings can achieve dramatic improvement in weight gain and linear growth in m...Continue Reading

Citations

Apr 10, 1997·British Journal of Nursing : BJN·C E HoldenI W Booth
Oct 20, 2001·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·O G AzoozA B Ballinger
Oct 13, 2006·Current Opinion in Gastroenterology·E Cabré, M A Gassull
Nov 30, 2007·Alimentary Pharmacology & Therapeutics·A S DayD A Lemberg
Feb 13, 2008·Inflammatory Bowel Diseases·Robert HeuschkelAnne Griffiths
Jan 19, 2010·Journal of Pediatric Gastroenterology and Nutrition·Bhupinder K SandhuUNKNOWN IBD Working Group of the British Society of Paediatric Gastroenterology, Hepatology, and Nutrition
Nov 1, 1994·Indian Journal of Pediatrics·A G Thomas
Jan 1, 1996·Scandinavian Journal of Gastroenterology. Supplement·S J O'Keefe
Aug 1, 2006·Journal of Pediatric Gastroenterology and Nutrition·S C WongS F Ahmed
Sep 5, 2007·Alimentary Pharmacology & Therapeutics·P DziechciarzH Szajewska
Sep 12, 2015·Journal of Internal Medicine·P Malmborg, H Hildebrand
Jan 1, 1991·Acta Paediatrica Scandinavica. Supplement·I W Booth
Jan 1, 1991·Archives of Disease in Childhood·C E HoldenI W Booth
Nov 4, 2000·Nutrition Reviews·C Ashley, L Howard
Aug 2, 2001·Journal of Pediatric Gastroenterology and Nutrition·P KundhalA M Griffiths
Jul 24, 1998·Clinical Pediatrics·R Wyllie, S Sarigol
Apr 28, 2005·Alimentary Pharmacology & Therapeutics·U Vespasiani GentilucciM Cicala
Jan 31, 2007·Inflammatory Bowel Diseases·Raanan ShamirArie Levine
Aug 29, 2006·World Journal of Gastroenterology : WJG·Carsten Büning, Herbert Lochs
Jan 19, 2010·Journal of Pediatric Gastroenterology and Nutrition·D C WilsonS H Murch
Aug 10, 2011·JPEN. Journal of Parenteral and Enteral Nutrition·Forbes AlastairPaulon Emma
Jun 1, 1991·Archives of Disease in Childhood·I W Booth
Jul 1, 1993·Gut·A M GriffithsP M Sherman
Nov 14, 2001·Current Opinion in Clinical Nutrition and Metabolic Care·M A Gassull, E Cabré
Apr 13, 2004·Journal of Pediatric Gastroenterology and Nutrition·Kaushik BannerjeeNicholas M Croft
Nov 1, 1994·Indian Journal of Pediatrics·N K Mittal, B S Kirschner
Aug 26, 1999·Scottish Medical Journal·D R Gaya
Sep 28, 2002·Current Opinion in Pediatrics·Jeffrey S Hyams
Aug 24, 1999·Inflammatory Bowel Diseases·R M Issenman
May 2, 2013·Therapeutic Advances in Gastroenterology·Clare F DonnellanSimon Lal
Jul 3, 2010·Expert Review of Clinical Immunology·Anthony R OtleyAndew S Day
Sep 1, 1996·Digestive Diseases and Sciences·G ZoliM J Farthing
Sep 1, 1992·Digestive Diseases and Sciences·F PigotB Amor
Jun 1, 1991·Alimentary Pharmacology & Therapeutics·R I Russell
Aug 29, 2009·Nature Reviews. Gastroenterology & Hepatology·Thomas D Walters, Anne M Griffiths
Jun 28, 2005·JPEN. Journal of Parenteral and Enteral Nutrition·Ian R Sanderson, Nicholas M Croft
Oct 24, 1998·Nutrition·A M Griffiths
Aug 1, 1997·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·S KleinP Twomey
May 16, 2006·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·H LochsUNKNOWN ESPEN (European Society for Parenteral and Enteral Nutrition)
Nov 1, 1991·Disease-a-month : DM·J B Kirsner
Mar 1, 1994·Baillière's Clinical Gastroenterology·C E Brain, M O Savage

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.